sb 203580 has been researched along with lanthanum in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (lanthanum) | Trials (lanthanum) | Recent Studies (post-2010) (lanthanum) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 5,016 | 96 | 1,241 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hori, M; Karaki, H; Ozaki, H; Tasaki, K; Wakabayashi, I | 1 |
1 other study(ies) available for sb 203580 and lanthanum
Article | Year |
---|---|
Mechanism of human urotensin II-induced contraction in rat aorta.
Topics: Androstadienes; Animals; Aorta, Thoracic; Butadienes; Calcium; Carbazoles; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Humans; Imidazoles; Indoles; Lanthanum; Male; Maleimides; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Muscle Contraction; Myosin Light Chains; Nitriles; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Potassium Chloride; Protein Kinase C; Pyridines; Rats; Rats, Wistar; Thapsigargin; Urotensins; Verapamil; Wortmannin | 2004 |